Keywords: EV(s); extracellular vesicle(s); MV(s); microvesicle(s); AB(s); apoptotic bodie(s); TME; tumor microenvironment; TfRs; transferrin receptors; MVE; multivesicular endosomes; MHC; major histocompatibility complex; miRNAs; microRNAs; PCa; prostate cancer; ES
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AB; Apoptotic body; ADP; Adenosine diphosphate; Anx; Annexin; ASARM; Acidic serine- and aspartate-rich motif; ATP; Adenosine triphosphate; BMP; Bone morphogenetic protein; CK; Choline kinase; CKD; Chronic kidney disease; ECM; Extracellular matrix; GPI; Gl
Keywords: nSMase2; NEFH; Sphingomyelin Phosphodiesterase; 5-aza-2-deoxycitidine; ACTL6B; actin-like 6B; CHTN; cooperative tissue network; CpG; cytosine preceding guanine; DAC; 5-aza-2â²deoxycitidine; DGKI; diacylglycerol kinase, iota; ELOVL4; ELOVL fatty acid elon
Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2
Keywords: Tauopathy; nSMase2; Extracellular vesicles; Cambinol; Tau biosensor; Molecular modeling;
Biogenesis and function of extracellular vesicles in cancer
Keywords: EVs; extracellular vesicles; MVB; multivesicular body; ILVs; intraluminal Vesicles; nSMase2; neutral sphingomyelinase 2; ESCRT; endosomal sorting complex required for transport; ARF6; ADP ribosylation factor 6; PLD2; phospholipase D2; SNARE; soluble N-eth
The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity
Keywords: DMEM; Dulbecco's modified Eagle's medium; DMSO; dimethylsulfoxide; fro; fragilis ossium; HA; hyaluronic acid; HAS; HA synthase; HPTLC; high performance thin-layer chromatography; LC-MS/MS; liquid chromatography-tandem mass spectrometry; MES; 2-(N-morp
The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL
Keywords: Cer; ceramide; CAM; chorioallantoic membrane; HMEC-1; Human Microvascular Endothelial Cell-1; LDL; low density lipoproteins; mAb; monoclonal antibodies; nSMase2; neutral sphingomyelinase-2; oxLDL; oxidized LDL; ROS; reactive oxygen species; H2O2; hydrogen
Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway
Keywords: nSMase; neutral sphingomyelinase; nSMase2; type 2 neutral sphingomyelinase; SMC; smooth muscle cell; mFbl; mouse fibroblast; wt; wild type; fro; fragilitas ossium; mef; mouse embryonic fibroblast; MMP; matrix metalloproteinases; AnxA2; annexin 2; H2O2; hy
HDL drug carriers for targeted therapy
Keywords: HDL; high-density lipoprotein; SR-BI; scavenger receptor class B type I; eNOS; endothelial nitric oxide synthase; miRNAs; microRNAs; S1PRs; sphingosine 1-phosphate receptors; S1P; sphingosine 1-phosphate; PGI2; prostaglandin I2; COX-2; cyclooxygenase-2; F
Neutral sphingomyelinases and nSMase2: Bridging the gaps
Keywords: Neutral sphingomyelinase; nSMase2; Ceramide; Apoptosis